MSL Rare Disease Expansion

We have been engaged by our biopharmaceutical client to expand their existing MSL team for another launch set for 2020. This is yet another Rare Disease asset.

They currently have 3 marketed products and a very robust pipeline from Preclinical to Phase III.

This launch will be their 4th product to hit the market making a difference in the lives of patients.

The total MSL team will be 10 which allows you the uniqueness of working across therapeutic areas and having a diverse disease portfolio within the Rare Disease space.

The territories are listed below:

The goal for this expansion is to have the build out completed by the first half of Q2.

If you or a colleague have a minimum of 3 years MSL experience in Rare/Orphan Disease or Nephrology, contact a member or our team at 267-483-5233.

The Bandish Group, LLC
Life Sciences Executive Search
1432 Easton Road, Suite 2B
Warrington, PA 18976
www.bandishgroup.com